Unlike CRC cultures, BRAFV600E PMP models show neither a signaling upregulation of EGFR (expression or activity) nor ERK activation upon encorafenib treatment [Supplementary Fig. S5A; Fig. 3D (right)]. The gene discussed is EGFR; the disease is colorectal carcinoma.